Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis
作者： Hae Dong Woo , Kyeezu Kim , Jeongseon Kim
DOI: 10.1007/S10552-015-0663-8
关键词: C-reactive protein level 、 Hematology 、 Meta-analysis 、 C-reactive protein 、 Epidemiology 、 Inflammatory marker 、 Medicine 、 Colorectal cancer 、 Poor prognosis 、 Internal medicine 、 Oncology
摘要: Purpose C-reactive protein (CRP) is widely known as a major nonspecific systemic inflammatory marker. A number of previous studies have suggested that elevated preoperative CRP associated with poor prognosis in colorectal cancer. We aimed to explore the effects on cancer survival through meta-analysis.
springer.com
sci-hub.se 参考文章(53)
Kazuya Muguruma, Kenji Sugano, Masaichi Ohira, Masatsune Shibutani, Naoshi Kubo, Ryosuke Amano, Kiyoshi Maeda, Kenjiro Kimura, Tetsuro Ikeya, Hiroshi Ohtani, Hisashi Nagahara, Kosei Hirakawa, Hiroaki Tanaka, Elevated preoperative serum C-reactive protein levels are associated with poor survival in patients with colorectal cancer. Hepato-gastroenterology. ,vol. 61, pp. 2236- 2240 ,(2014)
Robert Benamouzig, Jacques Deyra, Antoine Martin, Bernard Girard, Eric Jullian, Benoit Piednoir, Daniel Couturier, Thierry Coste, Julian Little, Stanislas Chaussade, Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology. ,vol. 125, pp. 328- 336 ,(2003) , 10.1016/S0016-5085(03)00887-4
Tadahiro Nozoe, Rumi Matono, Hideki Ijichi, Takefumi Ohga, Takahiro Ezaki, Glasgow Prognostic Score (GPS) Can Be a Useful Indicator to Determine Prognosis of Patients With Colorectal Carcinoma International Surgery. ,vol. 99, pp. 512- 517 ,(2014) , 10.9738/INTSURG-D-13-00118.1
V K H Wong, H Z Malik, Z Z R Hamady, A Al-Mukhtar, D Gomez, K R Prasad, G J Toogood, J P A Lodge, C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases British Journal of Cancer. ,vol. 96, pp. 222- 225 ,(2007) , 10.1038/SJ.BJC.6603558
Lisa M. Coussens, Zena Werb, Inflammation and cancer Nature. ,vol. 420, pp. 860- 867 ,(2002) , 10.1038/NATURE01322
Yu-Chen Shiu, Jen-Kou Lin, Chi-Jung Huang, Jeng-Kai Jiang, Ling-Wei Wang, Huei-Chen Huang, Shung-Haur Yang, Is C-Reactive Protein a Prognostic Factor of Colorectal Cancer? Diseases of The Colon & Rectum. ,vol. 51, pp. 443- 449 ,(2008) , 10.1007/S10350-007-9133-Z
Robert S. Sandler, Susan Halabi, John A. Baron, Susan Budinger, Electra Paskett, Roger Keresztes, Nicholas Petrelli, J. Marc Pipas, Daniel D. Karp, Charles L. Loprinzi, Gideon Steinbach, Richard Schilsky, A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. The New England Journal of Medicine. ,vol. 348, pp. 883- 890 ,(2003) , 10.1056/NEJMOA021633
Yijie Han, Feng Mao, Ying Wu, Xiaonan Fu, Wei Zhang, Xiaoli Zhu, Shuli Zhou, Wei Zhang, Qiang Sun, Yulan Zhao, Prognostic role of C-reactive protein in breast cancer: a systematic review and meta-analysis. International Journal of Biological Markers. ,vol. 26, pp. 209- 215 ,(2011) , 10.5301/JBM.2011.8872
Tadahiro Nozoe, Emiko Mori, Ikuo Takahashi, Takahiro Ezaki, Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma Surgery Today. ,vol. 38, pp. 597- 602 ,(2008) , 10.1007/S00595-007-3680-8
Donald C. McMillan, Joseph E. M. Crozier, Khalid Canna, Wilson J. Angerson, Colin S. McArdle, Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. International Journal of Colorectal Disease. ,vol. 22, pp. 881- 886 ,(2007) , 10.1007/S00384-006-0259-6